论文信息 - Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors - 字舞流文

Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors

G. Kolovou | L. Rallidis | D. Tousoulis | C. Pitsavos | D. Alexopoulos | D. Tziakas | E. Liberopoulos | M. Elisaf | S. Pappas | P. Vardas | A. Achimastos | V. Kotsis | D. Richter | N. Papanas | K. Tsioufis | V. Athyros | A. Bargiota | G. Ntaios | I. Lekakis | K. Tziomalos | A. Melidonis | I. Goudevenos | I. Skoumas | E. Bilianou | A. Tselepis | D. Vlahakos | I. Ioannidis | V. Nikolaou | C. Vlachopoulos | C. Chrysochoou | N. Tentolouris | T. Alexandrides | E. Drogari | Emanouel Ganotakis | K. Tsioufis